IBM

2

Review clinical trials related to IBM. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis

This study will evaluate whether neuromuscular ultrasound and MRI can be used as imaging markers of bulbar involvement and swallowing dysfunction in individuals with inclusion body myositis (IBM). Researchers will compare imaging and clinical findings in participants with IBM with those in participants with other myopathies, ALS, PLS, and healthy volunteers. The study is a one-time visit. Study procedures may include neurological assessments, swallowing questionnaires, tongue strength testing, neuromuscular ultrasound, and MRI. The goal is to identify more sensitive and objective ways to assess bulbar dysfunction biomarkers.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Johns Hopkins UniversityUpdated: Sep 16, 2026Locations: 1
Eligibility criteria

Participants must have a confirmed diagnosis of inclusion body myositis (IBM), a... [+3]

Unable or unwilling to provide written informed consent. [+4]

Status: Recruiting

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/

Participants needed: 700
Trial details
Age: 7+Biological sex: AllType: ObservationalSponsor: Myositis International Health & Research Collaborative Alliance FoundationUpdated: Jan 28, 2026Locations: 1
Eligibility criteria

Ability to provide informed consent [+2]

Under the age of 7 years old [+1]